Showing results (651-660 of 1,335) with videos related to
Sort By:
Pageof 134
Journal of Diabetes|June 8, 2012
Coronary artery calcium scanning in asymptomatic patients with diabetes mellitus: a paradigm shiftHarvey S Hecht, Jagat NarulaJournal of Diabetes|September 9, 2015
Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitusAtsushi Hiraoka, Marie Ochi, Rie Matsuda, et al.Journal of Diabetes|September 11, 2015
Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in KoreansHong-Kyu Kim, Jung Bok Lee, Seon Ha Kim, et al.Journal of Diabetes|December 24, 2015
Anxiety symptoms and functioning in a community sample of individuals with type 2 diabetes: A longitudinal studySonya S Deschênes, Rachel J Burns, Norbert SchmitzJournal of Diabetes|January 20, 2016
Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicitiesRitesh Gupta, Anoop MisraJournal of Diabetes|January 11, 2016
Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targetsManel Mata-Cases, Dídac Mauricio, Josep Franch-NadalJournal of Diabetes|January 23, 2016
Age at menarche is associated with the prevalence of non-alcoholic fatty liver disease later in lifeJieli Lu, Jie Zhang, Rui Du, et al.Journal of Diabetes|December 18, 2015
Lung function and metabolic syndrome: Findings of National Health and Nutrition Examination Survey 2007–2010Earl S Ford, Timothy J Cunningham, Carla I MercadoJournal of Diabetes|May 20, 2016
Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, ChinaXiaoyuan Bao, Chao Yang, Kai Fang, et al.Journal of Diabetes|April 10, 2016
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 TrialShinji Taneda, Jacob Hyllested-Winge, Mari-Anne Gall, et al.Pageof 134